greeksoup/ stock research
Stock research / United States / NVS / Planned sales

Novartis AG planned insider sales

In the last twelve months insiders at Novartis AG filed 4 Form 144 notices of planned sales, 51,043 shares worth $8.1 million at the time of filing, from 2 sellers. The latest, filed 28 October 2026: Bulto Carulla Victor (officer), 6,000 shares worth $933,180, planned for around 28 October 2026 through Fidelity Brokerage Services LLC.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
28 October 2026Bulto Carulla VictorOfficer6,000$933,18028 October 2026None on Form 4 yetFidelity Brokerage Services LLCRestricted Stock VestingForm 144
30 April 2026Bulto Carulla VictorOfficer6,800$1.0 million30 April 2026No matching Form 4 saleFidelity Brokerage Services LLCRestricted Stock VestingForm 144
12 February 2026Marshall FionaOfficer30,743$5.0 million12 February 2026No matching Form 4 saleFidelity Brokerage Services LLCRestricted Stock VestingForm 144
9 February 2026Bulto Carulla VictorOfficer7,500$1.2 million9 February 2026No matching Form 4 saleFidelity Brokerage Services LLCRestricted Stock VestingForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?